In response to a request from Japan's Ministry of Health, Labor and Welfare, the National Hospital Organization - governing 145 national hospitals - disclosed the list of its adopted generic drugs on its web site as well as the national medical centers including the National Cancer Center and National Cardiovascular Center did (Marketletter March 2).
According to the NHO, these hospitals have adopted 2,082 generic medicines in total, in addition to 4,088 branded products. The Organization said the Pharmaceuticals Affairs Committee of each national hospital is deciding whether it will adopt copycat drugs after confirming their quality, as well as the supply and information-providing systems of generic drugmakers.
The MHLW expects that the further adoption of generic drugs by national hospitals and medical centers will facilitate the use of such products among other public and private medical hospitals throughout the nation.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze